·07/05/08 The tumor suppressor TSLC1/NeCL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM
·07/05/08 Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development
·07/05/08 egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation
·07/05/08 IL-6 blocks a discrete early step in lymphopoiesis
·07/05/08 RNA interference in biology and disease
·07/05/08 T/B lineage choice occurs prior to intrathymic Notch signaling
·07/05/08 Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance
·07/05/08 CD144 (Ve-cadherin) is transiently expressed by fetal liver hematopoietic stem cells
·07/05/08 LDL receptor cooperates with LDL receptor–related protein in regulating plasma levels of coagulation factor VIII in vivo
·07/05/08 Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A
·07/05/08 Localization of ADAMTS13 to the stellate cells of human liver
·07/05/08 B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis
·07/05/08 Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report
·07/05/08 PF4/heparin complexes are T cell–dependent antigens
·07/05/08 Identification and characterization of epitopes of the receptor for hyaluronic acid–mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2–positive patients with acute myeloid leukemia
·07/05/08 Osteopontin functionally activates dendritic cells and induces their differentiation toward a Th1-polarizing phenotype
·07/05/08 Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin- receptor expression
·07/05/08 Impaired interferon- production as a consequence of STAT4 deficiency after autologous hematopoietic stem cell transplantation for lymphoma
·07/05/08 HFe cross-talks with the MHC class I antigen presentation pathway
·07/05/08 TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment
·07/05/08 Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog
·07/05/08 BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients
·07/05/08 Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF
·07/05/08 Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation
·07/05/08 efficient marking of human cells with rapid but transient repopulating activity in autografted recipients
·07/05/08 In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
·07/05/08 Nonhemolytic antibody-induced loss of erythrocyte surface antigen
·07/05/08 engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1–infected lymphocytes
·07/05/08 Conservation of unique cell-surface CD antigen mosaics in HIV-1–infected individuals
·07/05/08 Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1
·07/05/08 The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature
·07/05/08 Immunoglobulin gene analysis reveals 2 distinct cells of origin for eBV-positive and eBV-negative Burkitt lymphomas
·07/05/08 Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori–independent status of low-grade gastric mucosa–associated lymphoid tissue lymphomas with or without t(11;18)(q
·07/05/08 Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
·07/05/08 Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma

1 [2] [下一页] [尾页]